HBsAg, Anti-HBs, Anti-HCV and Anti-HIV seroprevalence among patients admitted to our hospital; five-year retrospective data

immunodeficiency virus (HIV) infections are important health problems in our country as well as all over the world. We aimed to investigate the distribution of seropositivity of HBsAg, anti-HBs, anti-HCV anti-HCV and anti-HIV positivity were 2.3 % (1,808/77,562), 46.6% (20,975/45,045), 0.6% (456/73,223) and 0.05% (35/71,061) respectively. Of the 1,808 patients were positive for HBsAg, 55% were males, 45% were females. Of the 456 anti-HCV positive patients, 63.6% were females and 36.4% were males. When assessed by age groups, HBsAg positivity was found to be the highest in the age group 31-50 (38.1%) and lowest in the age group ≤ 18 (0.6%). Anti-HCV positivity was found to be the highest in the age group ≥65 (32%) and lowest in the age group ≤ 18 (2%). All patients who were found to be anti-HIV positive were male and the highest positivity rate was between the ages of 19-30. Conclusion: Our HBsAg, anti-HBS, anti-HCV and anti-HIV results were found to be similar with the country statistical data. There was significant difference in the seropositivity of HBsAg ( p <0,001), anti-HCV ( p <0,05) and anti-HIV ( p <0,001) during the measurement period.